Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Open Access
- 20 April 2023
- journal article
- letter
- Published by Elsevier in The Lancet Microbe
- Vol. 4 (7) , e488-E488
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protectionThe Lancet Infectious Diseases, 2023
- Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron InfectionNew England Journal of Medicine, 2022
- Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against OmicronNew England Journal of Medicine, 2022
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationJCI Insight, 2021